Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors

JIANG Bo; XU Jin-yi; Wu Xiao-ming; Hua Wei-yi

JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual InhibitorsJ. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.

Citation:

JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual InhibitorsJ. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.

Citation:

JIANG Bo, XU Jin-yi, Wu Xiao-ming, Hua Wei-yi. Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual InhibitorsJ. Chinese Journal of Modern Applied Pharmacy, 2008, (2): 109-114.

Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors

Graphical Abstract

Abstract

Abstract

Classical Non-Steroidal Anti-Inflammatory Drugs(NSAIDs)and selective Cyclooxygenase-2(COX-2)inhibitors present GI damage and diverse side effects for the treatment of inflammatory disease,which limited their clinical development.These compounds with equal

FullText(HTML)

References (0)

Cited By

Turn off MathJax

Article Contents

Advances in the Research on the Cyclooxygenase-2 and 5-Lipoxygenase Dual Inhibitors

Abstract

Catalog

Export File

Citation

Format

Content